196 related articles for article (PubMed ID: 24730271)
1. Biophysicochemical perspective of nanoparticle compatibility: a critically ignored parameter in nanomedicine.
Hassan S; Singh AV
J Nanosci Nanotechnol; 2014 Jan; 14(1):402-14. PubMed ID: 24730271
[TBL] [Abstract][Full Text] [Related]
2. Walking the line: The fate of nanomaterials at biological barriers.
Meng H; Leong W; Leong KW; Chen C; Zhao Y
Biomaterials; 2018 Aug; 174():41-53. PubMed ID: 29778981
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for imaging, sensing, and therapeutic intervention.
Bogart LK; Pourroy G; Murphy CJ; Puntes V; Pellegrino T; Rosenblum D; Peer D; Lévy R
ACS Nano; 2014 Apr; 8(4):3107-22. PubMed ID: 24641589
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Hydroxyapatite Nanoparticles in Regenerative Medicine and Nanomedicine.
Inam H; Sprio S; Tavoni M; Abbas Z; Pupilli F; Tampieri A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474056
[TBL] [Abstract][Full Text] [Related]
5. Systemic Review of Biodegradable Nanomaterials in Nanomedicine.
Su S; Kang PM
Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32244653
[TBL] [Abstract][Full Text] [Related]
6. What is the role of curvature on the properties of nanomaterials for biomedical applications?
Gonzalez Solveyra E; Szleifer I
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 May; 8(3):334-54. PubMed ID: 26310432
[TBL] [Abstract][Full Text] [Related]
7. Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine.
Damasco JA; Ravi S; Perez JD; Hagaman DE; Melancon MP
Nanomaterials (Basel); 2020 Nov; 10(11):. PubMed ID: 33147800
[TBL] [Abstract][Full Text] [Related]
8. Engineered nanomaterial uptake and tissue distribution: from cell to organism.
Kettiger H; Schipanski A; Wick P; Huwyler J
Int J Nanomedicine; 2013; 8():3255-69. PubMed ID: 24023514
[TBL] [Abstract][Full Text] [Related]
9. Interactions of Nanoparticles and Biosystems: Microenvironment of Nanoparticles and Biomolecules in Nanomedicine.
Auría-Soro C; Nesma T; Juanes-Velasco P; Landeira-Viñuela A; Fidalgo-Gomez H; Acebes-Fernandez V; Gongora R; Almendral Parra MJ; Manzano-Roman R; Fuentes M
Nanomaterials (Basel); 2019 Sep; 9(10):. PubMed ID: 31554176
[TBL] [Abstract][Full Text] [Related]
10. Nanoinformatics: emerging databases and available tools.
Panneerselvam S; Choi S
Int J Mol Sci; 2014 Apr; 15(5):7158-82. PubMed ID: 24776761
[TBL] [Abstract][Full Text] [Related]
11. From Dose to Response: In Vivo Nanoparticle Processing and Potential Toxicity.
Graham UM; Jacobs G; Yokel RA; Davis BH; Dozier AK; Birch ME; Tseng MT; Oberdörster G; Elder A; DeLouise L
Adv Exp Med Biol; 2017; 947():71-100. PubMed ID: 28168666
[TBL] [Abstract][Full Text] [Related]
12. Complement-dependent uptake of nanoparticles by blood phagocytes: brief overview and perspective.
Li Y; Moein Moghimi S; Simberg D
Curr Opin Biotechnol; 2024 Feb; 85():103044. PubMed ID: 38091875
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine--challenge and perspectives.
Riehemann K; Schneider SW; Luger TA; Godin B; Ferrari M; Fuchs H
Angew Chem Int Ed Engl; 2009; 48(5):872-97. PubMed ID: 19142939
[TBL] [Abstract][Full Text] [Related]
14. Nano meets biology: structure and function at the nanoparticle interface.
Moyano DF; Rotello VM
Langmuir; 2011 Sep; 27(17):10376-85. PubMed ID: 21476507
[TBL] [Abstract][Full Text] [Related]
15. Design of nanomaterials for applications in maternal/fetal medicine.
Irvin-Choy NS; Nelson KM; Gleghorn JP; Day ES
J Mater Chem B; 2020 Aug; 8(31):6548-6561. PubMed ID: 32452510
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.
Dobrovolskaia MA
J Control Release; 2015 Dec; 220(Pt B):571-83. PubMed ID: 26348388
[TBL] [Abstract][Full Text] [Related]
17. Understanding intracellular nanoparticle trafficking fates through spatiotemporally resolved magnetic nanoparticle recovery.
Sheridan E; Vercellino S; Cursi L; Adumeau L; Behan JA; Dawson KA
Nanoscale Adv; 2021 May; 3(9):2397-2410. PubMed ID: 36134166
[TBL] [Abstract][Full Text] [Related]
18. Mitigation of Amyloidosis with Nanomaterials.
Ke PC; Pilkington EH; Sun Y; Javed I; Kakinen A; Peng G; Ding F; Davis TP
Adv Mater; 2020 May; 32(18):e1901690. PubMed ID: 31183916
[TBL] [Abstract][Full Text] [Related]
19. Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.
Crist RM; Grossman JH; Patri AK; Stern ST; Dobrovolskaia MA; Adiseshaiah PP; Clogston JD; McNeil SE
Integr Biol (Camb); 2013 Jan; 5(1):66-73. PubMed ID: 22772974
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles and the blood coagulation system. Part II: safety concerns.
Ilinskaya AN; Dobrovolskaia MA
Nanomedicine (Lond); 2013 Jun; 8(6):969-81. PubMed ID: 23730696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
